Having trouble viewing this email? View in your browser.
ADVANZ PHARMA - SYMPOSIUM Sunday, 11 July 2021 13:15-15:15

PLACE IN THERAPY OF CONTEMPORARY
LIPOGLYCOPEPTIDES AND CEPHALOSPORINS
IN AN EVOLVING ENVIRONMENT

Chair: Prof Soriano
ESCMID appointed-Chair: Prof Bonomo

Challenges in antibiotic therapy of Gram-positive
and polymicrobial infections

• Prof Stefani / IT

Antibiotic stewardship and tolerability – Implications for the place
in therapy of contemporary Lipoglycopeptides and Cephalosporins

• Dr Ritchie / UK

Case reviews – Experience and evidence
for the use of Dalbavancin and Ceftobiprole

• Prof Soriano / ES

Update on the management of bacterial coinfections
in Covid-19 patients

• Prof Tascini / IT

Real-life pharmaco-economic analysis of Dalbavancin

• Dr Béraud & Prof Dinh / FR
For Healthcare Professionals Only ADV/MISC/PM/0032 June 2021



You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.